FDA Law

FEBRUARY 27, 2023

While no “special registration” will yet be required to engage in telemedicine prescribing of controlled substances, DEA is proposing parameters to guide the practice of telemedicine encounters in a post-COVID world. We will release exciting details of our upcoming webinar addressing telemedicine soon. 21 U.S.C. § 802(54)(D)(i).

Telemedicine 59

Telemedicine Telecommunication Telehealth Medical 59

PEMBlog

MAY 24, 2023

This entails utilizing the least invasive non-pharmacologic means of assisting them, before moving to physical or chemical restraints. Special thanks to Manpreet Singh, MD ( @MprizzleER ) for helping to put this collaboration together. Deaths due to physical restraint. Physical and chemical restraints. Dtsch Arztebl Int.

Management 54

Management Patient-Centered Physicals Transportation 54

FDA Law

MAY 19, 2022

The guidance offers an opportunity that could be of special interest to foreign manufacturers who already market infant formula in other countries and have considered entering the U.S. FDA announced a webinar to be held on May 20 th that will provide an overview of the guidance and give manufacturers an opportunity to ask questions.

Manufacturing 52

Manufacturing Specialization Physicals IT 52

GeriPal

SEPTEMBER 14, 2023

In addition to discussing these outcomes, we also discuss: The history of the hospital-at-home movement. The practicalities of how it works including who are good candidates, where does it start (the ED?), what happens at home, do you need a caregiver, what happens if they need something like imaging? How is it financed and what comes next?

Hospital 115

Hospital Patient-Centered Supply Chain IT 115